JPRN-UMIN000003584已完成未知
Switching from sulfonylurea to sitagliptin among type 2 diabetic patients in combination with metformin or pioglitazone. - Switching from sulfonylurea to sitagliptin in combination with metformin or pioglitazone.
Hokuriku Incretin-based Therapy Study Group0 个研究点目标入组 100 人开始时间: 2010年5月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients satisfying any of the following criteria; 1) receiving or having received sitagliptin 2) having neural diseases (including clinically overt cerebral infarction) but diabetic neuropathy 3) having arrhythmia or heart failure 4) having more than moderate renal dysfunction (sCr > 1.5 mg/dl in men, > 1.3 mg/dl in women) 5) having severe liver dysfunction 6) having malignancy 7) being pregnant, or breast-feeding 8) having any of contraindications for sitagliptin 9) having contraindications for both metformin and pioglitazone 10) suspected as pheochromocytoma, or having allergic history against glucagon
研究者
相似试验
已完成
不适用
Sitagliptin Add-on to Sulfonylurea Studytype 2 diabetesJPRN-UMIN000005498Kyoto University80
已完成
4 期
A Trial to investigate the efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes not achieving adequate glycaemic control on sitagliptin and metformiCTRI/2014/05/004623ovo Nordisk AS70
进行中（未招募）
不适用
Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes not achieving adequate glycaemic control on sitagliptin and metformiDiabetes Mellitus, Type 2MedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-004931-22-HUovo Nordisk A/S396
进行中（未招募）
不适用
Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes not achieving adequate glycaemic control on sitagliptin and metformiDiabetes Mellitus, Type 2MedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-004931-22-ESovo Nordisk A/S396
进行中（未招募）
不适用
Sitagliptin vs sulphonylurea based treatments in Muslim patients with Type 2 diabetes during Ramadan - Januvia vs sulphonylurea in Ramadan study 1Muslim patients with type 2 diabets fasting during RamadanEUCTR2008-002607-12-GBCentral Manchester& Manchester Children's University Hospitals NHS Trust200